Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Cardioprotection Mechanism in PCI
NCT02128022Phase 1Completed
- Start
- Jul 2014
- Primary completion
- Mar 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Glucagon-like peptide 1(7-36)-amide in angina pectoris (4 arms). Primary endpoint: Change in Isovolumetric Relaxation Constant - Tau. Started Jul 2014; status: completed.
02
Drugs
Glucagon-like peptide 1(7-36)-amide
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02128022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128022.